Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2024 07:59 ET | Source: Pasithea

Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers

Pasithea Tx (Nasdaq: KTTA) Phase 1 trial on PAS-004 for RAS, NF1, and RAF mutated cancers completes initial dosing, with safety data expected in 2H 2024.
December 11, 2023 08:01 ET | Source: Pasithea

Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models

Pasithea Therapeutics (Nasdaq: KTTA) announced positive preclinical efficacy in models conducted ahead of its planned Phase I, in-human trials in 1Q24.
November 29, 2023 07:59 ET | Source: Pasithea

Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development

Pasithea Therapeutics Discusses Outcome of Pre-IND Meeting with FDA for Clinical Development of its MEK inhibitor, PAS-004
June 01, 2023 07:57 ET | Source: Pasithea

Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference

PALO ALTO, Calif. and MIAMI, June 01, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
June 09, 2014 10:19 ET | Source: Children's Tumor Foundation

Media Alert: Innovative Business Opportunities in Neurofibromatosis

NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
June 06, 2014 16:54 ET | Source: Children's Tumor Foundation

KEY MEDIA OPPORTUNITIES AT THE 2014 NF FORUM/CONFERENCE

-- NIH Director Francis Collins to Deliver Keynote Address -- First-ever 'Business Opportunities in NF' Satellite Meeting NEW YORK, June 6, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor...
June 03, 2014 16:52 ET | Source: Children's Tumor Foundation

World's Largest Neurofibromatosis Conference to be Held in Washington, D.C.

NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference/Forum, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
March 10, 2014 11:33 ET | Source: Children's Tumor Foundation

Children's Tumor Foundation Announces Historic New Initiative in Neurofibromatosis Research

NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation, the leading non-governmental organization dedicated to neurofibromatosis (NF) research, announced today an important new...
January 15, 2014 14:16 ET | Source: Children's Tumor Foundation

Children's Tumor Foundation Announces Leadership Change

NEW YORK, Jan. 15, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) announced today that Annette Bakker, Chief Scientific Officer of the Foundation has been elevated to President,...